244 related articles for article (PubMed ID: 15694110)
1. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study.
Schiff R; Bulpitt CJ; Wesnes KA; Rajkumar C
Psychoneuroendocrinology; 2005 May; 30(4):309-15. PubMed ID: 15694110
[TBL] [Abstract][Full Text] [Related]
2. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women.
Pefanco MA; Kenny AM; Kaplan RF; Kuchel G; Walsh S; Kleppinger A; Prestwood K
J Am Geriatr Soc; 2007 Mar; 55(3):426-31. PubMed ID: 17341247
[TBL] [Abstract][Full Text] [Related]
3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
4. Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age.
Vinkers DJ; Stek ML; van der Mast RC; de Craen AJ; Le Cessie S; Jolles J; Westendorp RG; Gussekloo J
Neurology; 2005 Jul; 65(1):107-12. PubMed ID: 16009894
[TBL] [Abstract][Full Text] [Related]
5. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.
Almeida OP; Lautenschlager NT; Vasikaran S; Leedman P; Gelavis A; Flicker L
Neurobiol Aging; 2006 Jan; 27(1):141-9. PubMed ID: 16298249
[TBL] [Abstract][Full Text] [Related]
6. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.
Yaffe K; Vittinghoff E; Ensrud KE; Johnson KC; Diem S; Hanes V; Grady D
Arch Neurol; 2006 Jul; 63(7):945-50. PubMed ID: 16831962
[TBL] [Abstract][Full Text] [Related]
7. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
[TBL] [Abstract][Full Text] [Related]
8. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
Wroolie TE; Williams KE; Keller J; Zappert LN; Shelton SD; Kenna HA; Reynolds MF; Rasgon NL
J Clin Psychopharmacol; 2006 Aug; 26(4):361-6. PubMed ID: 16855452
[TBL] [Abstract][Full Text] [Related]
9. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
Joffe H; Hall JE; Gruber S; Sarmiento IA; Cohen LS; Yurgelun-Todd D; Martin KA
Menopause; 2006; 13(3):411-22. PubMed ID: 16735938
[TBL] [Abstract][Full Text] [Related]
10. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
[TBL] [Abstract][Full Text] [Related]
11. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
Shah S; Bell RJ; Savage G; Goldstat R; Papalia MA; Kulkarni J; Donath S; Davis SR
Menopause; 2006; 13(4):600-8. PubMed ID: 16837882
[TBL] [Abstract][Full Text] [Related]
12. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
Baksu B; Baksu A; Göker N; Citak S
Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
[TBL] [Abstract][Full Text] [Related]
13. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg.
Wesnes KA; Edgar C; Tretter RN; Bolodeoku J
Expert Opin Drug Saf; 2009 Nov; 8(6):615-26. PubMed ID: 19747069
[TBL] [Abstract][Full Text] [Related]
14. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women.
Fournier LR; Ryan Borchers TA; Robison LM; Wiediger M; Park JS; Chew BP; McGuire MK; Sclar DA; Skaer TL; Beerman KA
J Nutr Health Aging; 2007; 11(2):155-64. PubMed ID: 17435957
[TBL] [Abstract][Full Text] [Related]
15. Hot flashes and estrogen therapy do not influence cognition in early menopausal women.
LeBlanc ES; Neiss MB; Carello PE; Samuels MH; Janowsky JS
Menopause; 2007; 14(2):191-202. PubMed ID: 17194963
[TBL] [Abstract][Full Text] [Related]
16. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial.
Morrison MF; Kallan MJ; Ten Have T; Katz I; Tweedy K; Battistini M
Biol Psychiatry; 2004 Feb; 55(4):406-12. PubMed ID: 14960294
[TBL] [Abstract][Full Text] [Related]
17. Cognitive training in affective disorders improves memory: a preliminary study using the NEAR approach.
Naismith SL; Redoblado-Hodge MA; Lewis SJ; Scott EM; Hickie IB
J Affect Disord; 2010 Mar; 121(3):258-62. PubMed ID: 19616856
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
Kennedy DO; Jackson PA; Haskell CF; Scholey AB
Hum Psychopharmacol; 2007 Dec; 22(8):559-66. PubMed ID: 17902186
[TBL] [Abstract][Full Text] [Related]
19. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
Elsabagh S; Hartley DE; File SE
J Psychopharmacol; 2005 Mar; 19(2):173-81. PubMed ID: 15728439
[TBL] [Abstract][Full Text] [Related]
20. Effects of estradiol on the cognitive function of postmenopausal women.
Marinho RM; Soares JM; Santiago RC; Maganhin CC; Machado F; de Miranda Cota AM; Baracat EC
Maturitas; 2008; 60(3-4):230-4. PubMed ID: 18775608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
